260 related articles for article (PubMed ID: 35986111)
1. The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance.
Islam MR; Rahman MM; Ahasan MT; Sarkar N; Akash S; Islam M; Islam F; Aktar MN; Saeed M; Harun-Or-Rashid M; Hosain MK; Rahaman MS; Afroz S; Bibi S; Rahman MH; Sweilam SH
Environ Sci Pollut Res Int; 2022 Oct; 29(46):69341-69366. PubMed ID: 35986111
[TBL] [Abstract][Full Text] [Related]
2. Mucormycosis, past and present: a comprehensive review.
Gupta I; Baranwal P; Singh G; Gupta V
Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
[TBL] [Abstract][Full Text] [Related]
3. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.
Singh K; Kumar S; Shastri S; Sudershan A; Mansotra V
Immunogenetics; 2022 Apr; 74(2):197-206. PubMed ID: 34596728
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
[TBL] [Abstract][Full Text] [Related]
5. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
[TBL] [Abstract][Full Text] [Related]
6. Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications.
Gurunathan S; Lee AR; Kim JH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293381
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.
Rao VUS; Arakeri G; Madikeri G; Shah A; Oeppen RS; Brennan PA
Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1095-1098. PubMed ID: 34507870
[TBL] [Abstract][Full Text] [Related]
8. A systematic review on SARS-CoV-2-associated fungal coinfections.
Soni S; Namdeo Pudake R; Jain U; Chauhan N
J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
[TBL] [Abstract][Full Text] [Related]
9. Mucormycosis: An opportunistic pathogen during COVID-19.
Mahalaxmi I; Jayaramayya K; Venkatesan D; Subramaniam MD; Renu K; Vijayakumar P; Narayanasamy A; Gopalakrishnan AV; Kumar NS; Sivaprakash P; Sambasiva Rao KRS; Vellingiri B
Environ Res; 2021 Oct; 201():111643. PubMed ID: 34237335
[TBL] [Abstract][Full Text] [Related]
10. A Novel Deep Learning-Based Black Fungus Disease Identification Using Modified Hybrid Learning Methodology.
Karthikeyan S; Ramkumar G; Aravindkumar S; Tamilselvi M; Ramesh S; Ranjith A
Contrast Media Mol Imaging; 2022; 2022():4352730. PubMed ID: 35115902
[TBL] [Abstract][Full Text] [Related]
11. Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.
Devnath P; Dhama K; Tareq AM; Emran TB
Int J Surg; 2021 Aug; 92():106031. PubMed ID: 34311126
[No Abstract] [Full Text] [Related]
12. Mucormycosis in COVID-19 patients.
Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.
Bhanuprasad K; Manesh A; Devasagayam E; Varghese L; Cherian LM; Kurien R; Karthik R; Deodhar D; Vanjare H; Peter J; Michael JS; Thomas M; Samuel P; Varghese GM
Int J Infect Dis; 2021 Oct; 111():267-270. PubMed ID: 34450284
[TBL] [Abstract][Full Text] [Related]
14. Mucormycosis and COVID-19 an epidemic in a pandemic?
Banerjee I; Robinson J; Asim M; Sathian B; Banerjee I
Nepal J Epidemiol; 2021 Jun; 11(2):1034-1039. PubMed ID: 34290893
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression.
Tabassum T; Araf Y; Moin AT; Rahaman TI; Hosen MJ
Mol Biol Rep; 2022 Jan; 49(1):747-754. PubMed ID: 34709573
[TBL] [Abstract][Full Text] [Related]
16. The risk of cutaneous mucormycosis associated with COVID-19: A perspective from Pakistan.
Asri S; Akram MR; Hasan MM; Asad Khan FM; Hashmi N; Wajid F; Ullah I
Int J Health Plann Manage; 2022 Mar; 37(2):1157-1159. PubMed ID: 34476830
[TBL] [Abstract][Full Text] [Related]
17. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
[TBL] [Abstract][Full Text] [Related]
18. Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins.
Pushparaj K; Kuchi Bhotla H; Arumugam VA; Pappusamy M; Easwaran M; Liu WC; Issara U; Rengasamy KRR; Meyyazhagan A; Balasubramanian B
Sci Total Environ; 2022 Jan; 805():150355. PubMed ID: 34818767
[TBL] [Abstract][Full Text] [Related]
19. Mucor in a Viral Land: A Tale of Two Pathogens.
Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
[TBL] [Abstract][Full Text] [Related]
20. Is Mucormycosis an inevitable complication of Covid-19 in India?
Bhogireddy R; Krishnamurthy V; Jabaris S SL; Pullaiah CP; Manohar S
Braz J Infect Dis; 2021; 25(3):101597. PubMed ID: 34289382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
